This information is intended for UK healthcare professionals only.
This animation has been commissioned and funded by Pfizer Limited and developed in partnership with Guidelines in Practice. Pfizer Limited suggested the topic and presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The presenter was paid an honorarium by Pfizer Limited. The views and opinions expressed in the animation are not necessarily those of Pfizer Limited, or of Guidelines in Practice, its publisher, advisers, or advertisers. No part of this animation may be reproduced in any form without the permission of the publisher.
Pfizer Limited has had no involvement with content on this webpage other than the animation and associated description.
Aims of this Guidelines in Practice animation
- presents osteoarthritis (OA) as a long-term condition and a barrier to healthy ageing
- describes chronic pain in OA and its impact on patients and the NHS
- discusses the association between OA and other conditions
- discusses the impact of chronic pain from OA on a patient’s daily activities.
Date of preparation: May 2021